Isochroman-6-carboxamides as Highly Selective 5-HT1D Agonists: Potential New Treatment for Migraine without Cardiovascular Side Effects-Reference-Cited by-同舟云学术

Isochroman-6-carboxamides as Highly Selective 5-HT1D Agonists: Potential New Treatment for Migraine without Cardiovascular Side Effects

Published:1998-06-01 Issue:13 Volume:41 Page:2180-2183
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Ennis Michael D.¹,Ghazal Nabil B.¹,Hoffman Robert L.¹,Smith Martin W.¹,Schlachter Siusaidh K.¹,Lawson Charles F.¹,Im Wha Bin¹,Pregenzer Jeffrey F.¹,Svensson Kjell A.¹,Lewis Richard A.¹,Hall Edward D.¹,Sutter Dorothy M.¹,Harris Lorri T.¹,McCall Robert B.¹

Affiliation:

1. Pharmacia & Upjohn, Inc., Kalamazoo, Michigan 49001

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm980137o

Reference18 articles.

1. Impact of Sumatriptan on Workplace Productivity, Nonwork Activities, and Health-Related Quality of Life Among Hospital Employees With Migraine

2. Healthcare Resource and Lost Labour Costs of Migraine Headache in the US

3. Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta.

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enantioselective Synthesis of α‐Quaternary Isochromanes by Oxidative Aminocatalysis and Gold Catalysis;Chemistry – A European Journal;2024-05-23

2. The 5-HT1F receptor as the target of ditans in migraine — from bench to bedside;Nature Reviews Neurology;2023-07-12

3. Transition Metal‐Catalyzed Enantioselective Synthesis of Chiral Five‐ and Six‐Membered Benzo O‐heterocycles;The Chemical Record;2023-07-04

4. Asymmetric Synthesis of Cyclohexenone-Fused Isochromans via Quinidine-Catalyzed Domino Peroxyhemiacetalization/Oxa-Michael Addition/Desymmetrization Sequence;The Journal of Organic Chemistry;2022-04-19

5. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors;British Journal of Pharmacology;2021-09-16